Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures
- 19 July 2016
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 23 (2) , 148-154
Abstract
Adults with hemophilia A (HA), hemophilia B (HB), and von Willebrand disease (VWD) frequently require surgery and invasive procedures. However, there is variability in perioperative management guidelines. We describe our periprocedural outcomes in this setting. A retrospective chart review from January 2006 to December 2012 of patients with HA, HB, and VWD undergoing surgery or invasive procedures was conducted. Type of procedures, management including the use of continuous factor infusion, and administration of antifibrinolytics were reviewed. Adverse outcomes were defined as acute bleeding (<48 hours), delayed bleeding (≥48 hours), transfusion, inhibitor development, and thrombosis. We identified 59 patients with HA and HB. In all, 24 patients had severe hemophilia and 12 had mild/moderate hemophilia. Twelve patients had inhibitors. There were also 5 female carriers of HA and 6 patients with VWD. There were 34 major surgeries (26 orthopedic, 8 nonorthopedic) and 129 minor surgeries. Continuous infusion was used in 55.9% of major surgeries versus 8.5% of minor surgeries. Antifibrinolytics were administered in 14.7% of major surgeries versus 23.2% of minor surgeries. In all, 4 patients developed acute bleeding and 10 patients developed delayed bleeding. Delayed bleeding occurred in 28.6% of genitourinary procedures and in 16.1% of dental procedures. Five patients acquired an inhibitor and 2 had thrombosis. In conclusion, patients with HA, HB, or VWD had similar rates of adverse outcomes when undergoing minor surgeries or major surgeries. This finding underscores the importance of an interdisciplinary management and procedure-specific guidelines for patients with hemophilia and VWD prior to even minor invasive procedures.Keywords
This publication has 46 references indexed in Scilit:
- Molecular and clinical predictors of inhibitor risk and its prevention and treatment in mild hemophilia ABlood, 2014
- Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot studyHaemophilia, 2013
- Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysisWorld Journal of Urology, 2012
- Guidelines for the management of hemophiliaHaemophilia, 2012
- How we treat: patients with haemophilia undergoing screening colonoscopyHaemophilia, 2010
- Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendationsHaemophilia, 2009
- Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experienceHaemophilia, 2007
- Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia CentersHaemophilia, 2005
- Continuous Infusion of Coagulation Factor ProductsAnnals of Pharmacotherapy, 2002
- Acquired von Willebrand DiseaseMayo Clinic Proceedings, 2002